Serial Carcinoembryonic Antigen (CEA) monitoring aids early detection of gastrointestinal adenocarcinoma recurrence. Rising CEA levels can predict metastases or local recurrence up to 10 months before clinical diagnosis, improving patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: